Go to:
Logótipo
You are here: Start > Publications > View > Purinoceptor modulation of noradrenaline release in rat tail artery: Tonic modulation mediated by inhibitory P-2Y- and facilitatory A(2A)-purinoceptors
Concurso de Escrita Criativa da FEUP
Publication

Purinoceptor modulation of noradrenaline release in rat tail artery: Tonic modulation mediated by inhibitory P-2Y- and facilitatory A(2A)-purinoceptors

Title
Purinoceptor modulation of noradrenaline release in rat tail artery: Tonic modulation mediated by inhibitory P-2Y- and facilitatory A(2A)-purinoceptors
Type
Article in International Scientific Journal
Year
1996
Authors
Queiroz, G
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 117
Pages: 156-160
ISSN: 0007-1188
Publisher: Wiley-Blackwell
Scientific classification
FOS: Medical and Health sciences
Other information
Authenticus ID: P-001-F1F
Abstract (EN): 1 The effects of analogues of adenosine and ATP on noradrenaline release elicited by electrical stimulation (5 Hz, 2700 pulses) were studied in superfused preparations of rat tail artery. The effects of purinoceptor antagonists, of adenosine deaminase and of adenosine uptake blockade were also examined. Noradrenaline was measured by h.p.l.c, electrochemical detection. 2 The A(1)-adenosine receptor agonist, N-6-cyclopentyladenosine (CPA; 0.1-100 nM) reduced, whereas A(2A)-receptor agonist 2-p-(2-carboxyethyl)phenelhylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680; 3-30 nM) increased evoked noradrenaline overflow. These effects were antagonized by the A(1)-adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 20 nM) and the A(2)-adenosine receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX; 100 nM), respectively. The P-2Y-purinoceptor agonist, 2-methylthio-ATP (1-100 mu M) reduced noradrenaline overflow, an effect prevented by the P-2-purinoceptor antagonist, cibacron blue 3GA (100 mu M) and suramin (100 mu M). 3 Adenosine deaminase (2 u ml(-1)), DMPX (100 nM) and inhibition of adenosine uptake with S-(p-nitrobenzyl)-6-thioinosine (NBTI; 50 nM) decreased evoked noradrenaline overflow. DPCPX alone did not change noradrenaline overflow but prevented the inhibition caused by NBTI. The P-2Y-purinoceptor antagonist, cibacron blue 3GA (100 mu M) increased evoked noradrenaline overflow as did suramin, a nonselective P-2-antagonist. 4 It is concluded that, in rat tail artery, inhibitory (A(1) and P-2Y) and facilitatory (A(2A)) purinoceptors are present and modulate noradrenaline release evoked by electrical stimulation. Endogenous purines tonically modulate noradrenaline release through activation of inhibitory P-2Y and facilitatory A(2A) purinoceptors, whereas a tonic activation of inhibitory A(1) purinoceptors seems to be prevented by adenosine uptake.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication with allowed access.
Related Publications

Of the same journal

Human skin models: From healthy to disease-mimetic systems; characteristics and applications (2020)
Another Publication in an International Scientific Journal
Moniz, T; Costa Lima, SCA; Salette Reis
Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels (2015)
Article in International Scientific Journal
Coelho, A; Wolf Johnston, AS; Shinde, S; Cruz C.D.; Francisco Cruz; António Avelino Silva; Birder, LA
The role of the endocardium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle (1996)
Article in International Scientific Journal
Vaz Da Silva, M; Magina, S; Domingues-Costa, A; Moura, D; Guimarães, S

See all (65)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-08-23 at 16:29:33 | Acceptable Use Policy | Data Protection Policy | Complaint Portal